-
公开(公告)号：KR101382115B1
公开(公告)日：2014-04-08
申请号：KR1020070097813
申请日：2007-09-28
Applicant: (주)아모레퍼시픽
CPC classification number: Y02A40/948
Abstract: 본 발명은 인삼열매 추출물을 함유하는 아토피 피부염 개선용 식품 조성물에 관한 것으로서, 보다 상세하게는 인삼의 지상부 중에서 인삼근과 차별적 성분과 조성을 갖는 인삼열매 추출물을 유효성분으로 하여 표피를 통한 수분 손실량(TEWL: trans epidermal water loss)을 감소시키고 소양증(가려움증)을 감소시킴으로써 피부 표피 장벽의 지방 층상 구조가 손상되어 있는 아토피 피부염 또는 건조증 개선용 식품 조성물에 관한 것이다.
인삼열매 추출물, 아토피 피부염, 수분손실량(TEWL), 소양증(가려움증)-
公开(公告)号：KR101294093B1
公开(公告)日：2013-08-08
申请号：KR1020060111584
申请日：2006-11-13
Applicant: (주)아모레퍼시픽
Abstract: 본 발명은 손상된 피부장벽의 개선 효능이 있는 자초 추출물 또는 이를 포함한 혼합물을 함유하는 식이 조성물에 관한 것이다. 보다 상세하게는 피부장벽 손상에 의한 세라마이드 감소 및 소양증 개선에 뛰어난 효과가 있는 자초 추출물 또는 이를 포함한 혼합물을 함유하는 기능성 식이소재 조성물에 관한 것이다.
자초, 피부장벽, 세라마이드, 소양증-
公开(公告)号：KR1020080113504A
公开(公告)日：2008-12-31
申请号：KR1020070062055
申请日：2007-06-25
Applicant: (주)아모레퍼시픽
IPC: A61K36/258 , A61Q11/00 , A61K8/97
Abstract: A composition with an antibacterial effect on oral bacteria containing extracts of ginseng berries as an active ingredient is provided to ensure excellent antibacterial activity about the harmfulness oral microorganism, having low minimum inhibitory concentration while minimizing side effects. A composition with an antibacterial effect on oral bacteria comprises extracts of ginseng berries as an active ingredient. The ginseng fruit extract is crude saponin. The crude saponin is manufactured by adding ethanol to the dried material of ginseng berries, reflux-extracting, filtering and concentrating it; and after adding butanol after removing the fat-soluble component, extracting and concentrating it.
Abstract translation: 提供对含有人参浆果提取物的口腔细菌作为活性成分具有抗菌作用的组合物，以确保对有害性口腔微生物具有优异的抗菌活性，具有低的最小抑制浓度，同时尽量减少副作用。 对口腔细菌具有抗菌作用的组合物含有人参浆果提取物作为活性成分。 人参果实提取物是粗皂苷。 通过向人参浆果干燥物中加入乙醇制备粗皂苷，回流提取，过滤并浓缩; 除去脂溶性成分后加入丁醇，萃取浓缩。
-
公开(公告)号：KR1020080105470A
公开(公告)日：2008-12-04
申请号：KR1020070053097
申请日：2007-05-31
Applicant: (주)아모레퍼시픽
CPC classification number: A23L1/3002 , A23L33/105 , A23V2002/00 , A61K8/97 , A61K36/258 , A61K2800/522 , A61Q19/02 , A61Q19/08 , A23V2250/2124 , A23V2200/318 , A23V2200/332
Abstract: A food composition is provided to prevent and improve obesity by enhancing the expression of CPT-1 gene limiting the velocity in the oxidation of fat and by promoting the degradation of fat. A food composition for preventing obesity contains an extract of the fruit of insam (ginseng) as an active ingredient. Preferably the food composition expresses the Carnitine Palmitoyl Transferase-1 (CPT-1) gene. Preferably the extract of the fruit of insam is obtained by common extraction method.
Abstract translation: 提供食物组合物，通过增强CPT-1基因的表达来限制脂肪氧化速度和促进脂肪降解来预防和改善肥胖。 用于预防肥胖的食物组合物含有作为活性成分的insam（人参）的果实的提取物。 优选地，食物组合物表达肉碱棕榈酰转移酶-1（CPT-1）基因。 优选通过普通提取方法获得insam的果实提取物。
-
公开(公告)号：KR1020080104600A
公开(公告)日：2008-12-03
申请号：KR1020070051593
申请日：2007-05-28
Applicant: (주)아모레퍼시픽
IPC: A61K36/258 , A61P9/10 , A61P19/02
CPC classification number: A61K36/258 , A23L33/105 , A23V2002/00 , A61K9/0019 , A61K9/0095 , A61K9/1652 , A61K9/2018 , A61K9/4875 , A61K31/198 , A23V2250/2124 , A23V2200/318 , A23V2200/326 , A61K2300/00
Abstract: A composition for promoting the blood circulation is provided to promote the blood circulation by expanding the blood vessel and to inhibit the aging of the blood vessel. A composition for promoting the blood circulation contains an extract of the fruit of insam (ginseng) as an effective ingredient. Preferably the extract of the fruit of insam is prepared by adding ethanol to the dried one of insam fruit to reflux it for extraction, and filtering and concentrating the obtained extract; and removing the oil-soluble component, adding butanol to it to extract it, and concentrating the obtained extract.
Abstract translation: 提供促进血液循环的组合物，以通过扩张血管来促进血液循环，并抑制血管的老化。 用于促进血液循环的组合物含有作为有效成分的insam（人参）水果的提取物。 优选地，通过将乙醇加入到干燥的塞米果中以回流以提取来制备insam果实的提取物，并过滤并浓缩所得提取物; 除去油溶性成分，向其中加入丁醇进行萃取，浓缩得到的提取物。
-
Patent Agency Ranking
公开(公告)号：KR100833705B1
公开(公告)日：2008-05-29
申请号：KR1020020088024
申请日：2002-12-31
Applicant: (주)아모레퍼시픽
IPC: A61K36/185 , A61P9/08
Abstract: 본 발명은 우수한 혈관이완효과를 갖는 Orira(
Anogeissus leiocarpus ), Gboigboi(
Cnestis sp .) 또는 Osusu(
Drypetes molunduana) 추출물을 함유하는 혈액순환제 또는 혈관이완제에 관한 것이다. 보다 상세하게는, 아프리카에서 자생하는 Orira(
Anogeissus leiocarpus ), Gboigboi(
Cnestis sp .) 및 Osusu(
Drypetes molunduana) 의 뿌리를 유기용매로 추출한 추출물 및 상기 추출물을 유기용매로 분획화한 분획물을 함유하는 혈액순환제 또는 혈관이완제에 관한 것이다.
Orira * Gboiboi * Osusu * 혈관 이완 * 혈액 순환 * 5-HT-
公开(公告)号：KR1020040061732A
公开(公告)日：2004-07-07
申请号：KR1020020088024
申请日：2002-12-31
Applicant: (주)아모레퍼시픽
IPC: A61K36/185 , A61P9/08
Abstract: PURPOSE: Provided are extracts of Anogeissus leiocarpus, Cnestis sp. and Drypetes molunduana and fractions thereof which are used as raw materials of blood circulating agents and blood vessel relaxants. CONSTITUTION: Blood circulating agents and blood vessel relaxants are characterized by containing at least one kind of extracts of Anogeissus leiocarpus, Cnestis sp. and Drypetes molunduana and fractions thereof. The extracts are obtained by using methanol as an extraction solvent, filtering the extracts, concentrating the filtrates and drying them. A pharmaceutical composition contains at least one kind of the extracts of Anogeissus leiocarpus, Cnestis sp. and Drypetes molunduana.
Abstract translation: 目的：提供of藜（Anogeissus leiocarpus），Cnestis sp。 和Drypetes molunduana及其级分，用作血液循环剂和血管松弛剂的原料。 构成：血液循环剂和血管松弛剂的特征在于含有至少一种Anogeissus leiocarpus，Cnestis sp。 和Drypetes molunduana及其级分。 通过使用甲醇作为提取溶剂获得提取物，过滤提取物，浓缩滤液并干燥。 一种药物组合物含有至少一种Anogeissus leiocarpus，Cnestis sp。 和Drypetes molunduana。
-
公开(公告)号：KR101743489B1
公开(公告)日：2017-06-05
申请号：KR1020160009263
申请日：2016-01-26
Applicant: (주)아모레퍼시픽
IPC: A61K36/258 , A23L1/30
Abstract: 본발명은인삼열매추출물을유효성분으로함유하는혈행촉진용조성물, 혈관노화방지용조성물, 혈관염증치료용조성물, 혈관생성촉진용조성물, 허혈성심질환치료용조성물및 국부혈류부족개선및 치료용조성물에관한발명으로서, 더욱상세하게는, 인삼열매추출물을유효성분으로함유하여혈관내피세포에서일산화질소(NO)생성을촉진시키고, 혈관내피세포의생존을증진시키며, 혈관내피세포의이동성증가와혈관튜브생성을통한혈관신생을촉진시키는조성물에관한발명이다.
-
公开(公告)号：KR101668447B1
公开(公告)日：2016-10-24
申请号：KR1020090022588
申请日：2009-03-17
Applicant: (주)아모레퍼시픽
Abstract: 본발명은숙취해소용조성물및 이를포함하는건강기능식품에관한것으로, 홍삼, 산수유, 오미자및 토사자의추출물을포함하고, 추가로홍삼칩을포함할수 있다. 본발명은생약성분을이용하여부작용이없으며, 숙취해소에우수한효과를갖고, 당침된홍삼칩을포함함으로써우수한섭취만족도를제공할수 있다.
-
公开(公告)号：KR1020140097097A
公开(公告)日：2014-08-06
申请号：KR1020140092769
申请日：2014-07-22
Applicant: (주)아모레퍼시픽
IPC: A61K36/258 , A61P7/00 , A61P17/00
Abstract: The present invention relates to a composition containing a ginseng berry extract as an active ingredient for facilitation of blood circulation, prevention of vascular aging, treatment of vascular inflammation, facilitation of angiogenesis, treatment of ischemic heart disease, and improvement and treatment of local blood circulation insufficiency. More specifically, the present invention relates to a composition containing ginseng berry extract as an active ingredient to promote nitric oxide (NO) generation in endothelial cells, improve viability of endothelial cells, and promote angiogenesis through increased mobility of endothelial cells and vascular tube formation.
Abstract translation: 本发明涉及含有人参浆果提取物作为促进血液循环，预防血管老化，血管发生的治疗，促进血管生成，治疗缺血性心脏病以及改善和治疗局部血液循环的活性成分的组合物 功能不全。 更具体地，本发明涉及含有人参浆果提取物作为活性成分的组合物，以促进内皮细胞中的一氧化氮（NO）产生，提高内皮细胞的活力，并通过增加内皮细胞的活动性和血管形成来促进血管生成。
-
-
-
-
-
-
-
-
-
Search Results
51
records
(took 0.049 seconds)
